Login to Your Account



Pharma: Clinic Roundup


Friday, February 10, 2012
• Grupo Ferrer International SA, of Barcelona, Spain, said lorediplon was well tolerated and demonstrated efficacy comparable to or in excess of Ambien (zolpidem, Sanofi SA) in a Phase I insomnia trial.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription